News Item

  • Press Release
  • October 8, 2020

Dr. Regina Benjamin to Advise on Access to Precision Medicine Driving Better Health Outcomes for Patients with Autoimmune Diseases OCTOBER...

News Item

  • Press Release
  • September 17, 2020

PrismRA® first-of-its-kind molecular signature test validated in Ambry’s central laboratory. Partnership provides infrastructure for rapid scaling and patient accessibility.

News Item

  • Publication
  • September 14, 2020

Scipher Medicine is a spin-out of Northeastern University founded on the basis of, first, building a map of human biology...

News Item

  • Press Release
  • August 27, 2020

AMCP Science & Innovation Theater Webinar Speakers: James T. Kenney, MBA, RPh, President, JTKENNEY, LLC Alif Saleh, CEO, Scipher Medicine...

News Item

  • Press Release
  • July 28, 2020

PrismRA identifies patients 6.6 times less likely to respond to TNFi therapy JULY 28, 2020- WALTHAM, MA- (Business Wire)- Scipher Medicine,...

News Item

  • Publication
  • July 14, 2020
  • https://www.liebertpub.com/doi/10.1089/nsm.2020.0007

Abstract Objectives: For rheumatoid arthritis (RA) patients failing to achieve treatment targets with conventional synthetic disease-modifying antirheumatic drugs, tumor necrosis factor...

News Item

  • Article
  • April 1, 2019
  • Electronic Health Reporter